iNKT Cells Induce FGF21 for Thermogenesis and Are Required for Maximal Weight Loss in GLP1 Therapy

Cell Metabolism

Volumn 24, Issue 3, 2016, Pages 510-519

  Lynch, Lydia ^a   Hogan, Andrew E ^b   Duquette, Danielle ^a   Lester, Chantel ^a   Banks, Alexander ^a   LeClair, Katherine ^c   Cohen, David E ^c   Ghosh, Abhisek ^a   Lu, Bing ^a   Corrigan, Michelle ^b   Stevanovic, Darko ^d   Maratos Flier, Eleftheria ^d   Drucker, Daniel J ^e   O'Shea, Donal ^b   Brenner, Michael ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b ST VINCENT S UNIVERSITY HOSPITAL   (Ireland)

^c HARVARD MEDICAL SCHOOL   (United States)

^d BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^e MOUNT SINAI HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; ALPHA GALACTOSYLCERAMIDE; FIBROBLAST GROWTH FACTOR 21; GLUCAGON LIKE PEPTIDE 1; LIRAGLUTIDE; FIBROBLAST GROWTH FACTOR;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY FAT; CELL ACTIVATION; CONTROLLED STUDY; FAT MASS; GLYCEMIC CONTROL; IN VITRO STUDY; IN VIVO STUDY; LIPID STORAGE; MOUSE; NATURAL KILLER T CELL; NONHUMAN; OBESITY; PRIORITY JOURNAL; SATIETY; THERMOGENESIS; WEIGHT REDUCTION; WHITE ADIPOSE TISSUE; ANALOGS AND DERIVATIVES; ANIMAL; BROWN ADIPOSE TISSUE; C57BL MOUSE; DRUG EFFECTS; HUMAN; METABOLISM;

ADIPOSE TISSUE, BROWN; ADIPOSE TISSUE, WHITE; ANIMALS; FIBROBLAST GROWTH FACTORS; GLUCAGON-LIKE PEPTIDE 1; HUMANS; LIRAGLUTIDE; MICE, INBRED C57BL; NATURAL KILLER T-CELLS; THERMOGENESIS; WEIGHT LOSS;

EID: 84990848453     PISSN: 15504131     EISSN: 19327420     Source Type: Journal    
DOI: 10.1016/j.cmet.2016.08.003     Document Type: Article

References (38)

1. Badman, M.K., Koester, A., Flier, J.S., Kharitonenkov, A., Maratos-Flier, E., Fibroblast growth factor 21-deficient mice demonstrate impaired adaptation to ketosis. Endocrinology 150 (2009), 4931–4940.
2. Baggio, L.L., Drucker, D.J., Biology of incretins: GLP-1 and GIP. Gastroenterology 132 (2007), 2131–2157.
3. Brestoff, J.R., Kim, B.S., Saenz, S.A., Stine, R.R., Monticelli, L.A., Sonnenberg, G.F., Thome, J.J., Farber, D.L., Lutfy, K., Seale, P., Artis, D., Group 2 innate lymphoid cells promote beiging of white adipose tissue and limit obesity. Nature 519 (2015), 242–246.
4. Brigl, M., Brenner, M.B., CD1: antigen presentation and T cell function. Annu. Rev. Immunol. 22 (2004), 817–890.
5. Cousin, B., Cinti, S., Morroni, M., Raimbault, S., Ricquier, D., Pénicaud, L., Casteilla, L., Occurrence of brown adipocytes in rat white adipose tissue: molecular and morphological characterization. J. Cell Sci. 103 (1992), 931–942.
6. Enerbäck, S., The origins of brown adipose tissue. N. Engl. J. Med. 360 (2009), 2021–2023.
7. Enerbäck, S., Jacobsson, A., Simpson, E.M., Guerra, C., Yamashita, H., Harper, M.E., Kozak, L.P., Mice lacking mitochondrial uncoupling protein are cold-sensitive but not obese. Nature 387 (1997), 90–94.
8. Fisher, F.M., Kleiner, S., Douris, N., Fox, E.C., Mepani, R.J., Verdeguer, F., Wu, J., Kharitonenkov, A., Flier, J.S., Maratos-Flier, E., Spiegelman, B.M., FGF21 regulates PGC-1α and browning of white adipose tissues in adaptive thermogenesis. Genes Dev. 26 (2012), 271–281.
9. Gaich, G., Chien, J.Y., Fu, H., Glass, L.C., Deeg, M.A., Holland, W.L., Kharitonenkov, A., Bumol, T., Schilske, H.K., Moller, D.E., The effects of LY2405319, an FGF21 analog, in obese human subjects with type 2 diabetes. Cell Metab. 18 (2013), 333–340.
10. Hadjiyanni, I., Siminovitch, K.A., Danska, J.S., Drucker, D.J., Glucagon-like peptide-1 receptor signalling selectively regulates murine lymphocyte proliferation and maintenance of peripheral regulatory T cells. Diabetologia 53 (2010), 730–740.
11. Hams, E., Locksley, R.M., McKenzie, A.N., Fallon, P.G., Cutting edge: IL-25 elicits innate lymphoid type 2 and type II NKT cells that regulate obesity in mice. J. Immunol. 191 (2013), 5349–5353.
12. Hanssen, M.J., Broeders, E., Samms, R.J., Vosselman, M.J., van der Lans, A.A., Cheng, C.C., Adams, A.C., van Marken Lichtenbelt, W.D., Schrauwen, P., Serum FGF21 levels are associated with brown adipose tissue activity in humans. Sci. Rep., 5, 2015, 10275.
13. Harder, H., Nielsen, L., Tu, D.T., Astrup, A., The effect of liraglutide, a long-acting glucagon-like peptide 1 derivative, on glycemic control, body composition, and 24-h energy expenditure in patients with type 2 diabetes. Diabetes Care 27 (2004), 1915–1921.
14. Himms-Hagen, J., Cui, J., Danforth, E. Jr., Taatjes, D.J., Lang, S.S., Waters, B.L., Claus, T.H., Effect of CL-316,243, a thermogenic beta 3-agonist, on energy balance and brown and white adipose tissues in rats. Am. J. Physiol. 266 (1994), R1371–R1382.
15. Hogan, A.E., Tobin, A.M., Ahern, T., Corrigan, M.A., Gaoatswe, G., Jackson, R., O'Reilly, V., Lynch, L., Doherty, D.G., Moynagh, P.N., et al. Glucagon-like peptide-1 (GLP-1) and the regulation of human invariant natural killer T cells: lessons from obesity, diabetes and psoriasis. Diabetologia 54 (2011), 2745–2754.
16. Hogan, A.E., Gaoatswe, G., Lynch, L., Corrigan, M.A., Woods, C., O'Connell, J., O'Shea, D., Glucagon-like peptide 1 analogue therapy directly modulates innate immune-mediated inflammation in individuals with type 2 diabetes mellitus. Diabetologia 57 (2014), 781–784.
17. Holland, W.L., Adams, A.C., Brozinick, J.T., Bui, H.H., Miyauchi, Y., Kusminski, C.M., Bauer, S.M., Wade, M., Singhal, E., Cheng, C.C., et al. An FGF21-adiponectin-ceramide axis controls energy expenditure and insulin action in mice. Cell Metab. 17 (2013), 790–797.
18. Huh, J.Y., Kim, J.I., Park, Y.J., Hwang, I.J., Lee, Y.S., Sohn, J.H., Lee, S.K., Alfadda, A.A., Kim, S.S., Choi, S.H., et al. A novel function of adipocytes in lipid antigen presentation to iNKT cells. Mol. Cell. Biol. 33 (2013), 328–339.
19. Ji, Y., Sun, S., Xia, S., Yang, L., Li, X., Qi, L., Short term high fat diet challenge promotes alternative macrophage polarization in adipose tissue via natural killer T cells and interleukin-4. J. Biol. Chem. 287 (2012), 24378–24386.
20. Kharitonenkov, A., Adams, A.C., Inventing new medicines: the FGF21 story. Mol. Metab. 3 (2013), 221–229.
21. Kharitonenkov, A., Shiyanova, T.L., Koester, A., Ford, A.M., Micanovic, R., Galbreath, E.J., Sandusky, G.E., Hammond, L.J., Moyers, J.S., Owens, R.A., et al. FGF-21 as a novel metabolic regulator. J. Clin. Invest. 115 (2005), 1627–1635.
22. Lee, M.W., Odegaard, J.I., Mukundan, L., Qiu, Y., Molofsky, A.B., Nussbaum, J.C., Yun, K., Locksley, R.M., Chawla, A., Activated type 2 innate lymphoid cells regulate beige fat biogenesis. Cell 160 (2015), 74–87.
23. Lockie, S.H., Heppner, K.M., Chaudhary, N., Chabenne, J.R., Morgan, D.A., Veyrat-Durebex, C., Ananthakrishnan, G., Rohner-Jeanrenaud, F., Drucker, D.J., DiMarchi, R., et al. Direct control of brown adipose tissue thermogenesis by central nervous system glucagon-like peptide-1 receptor signaling. Diabetes 61 (2012), 2753–2762.
24. Lovshin, J.A., Drucker, D.J., Incretin-based therapies for type 2 diabetes mellitus. Nat. Rev. Endocrinol. 5 (2009), 262–269.
25. Lynch, L., O'Shea, D., Winter, D.C., Geoghegan, J., Doherty, D.G., O'Farrelly, C., Invariant NKT cells and CD1d(+) cells amass in human omentum and are depleted in patients with cancer and obesity. Eur. J. Immunol. 39 (2009), 1893–1901.
26. Lynch, L., Nowak, M., Varghese, B., Clark, J., Hogan, A.E., Toxavidis, V., Balk, S.P., O'Shea, D., O'Farrelly, C., Exley, M.A., Adipose tissue invariant NKT cells protect against diet-induced obesity and metabolic disorder through regulatory cytokine production. Immunity 37 (2012), 574–587.
27. Lynch, L., Michelet, X., Zhang, S., Brennan, P.J., Moseman, A., Lester, C., Besra, G., Vomhof-Dekrey, E.E., Tighe, M., Koay, H.F., et al. Regulatory iNKT cells lack expression of the transcription factor PLZF and control the homeostasis of T(reg) cells and macrophages in adipose tissue. Nat. Immunol. 16 (2015), 85–95.
28. Molofsky, A.B., Nussbaum, J.C., Liang, H.E., Van Dyken, S.J., Cheng, L.E., Mohapatra, A., Chawla, A., Locksley, R.M., Innate lymphoid type 2 cells sustain visceral adipose tissue eosinophils and alternatively activated macrophages. J. Exp. Med. 210 (2013), 535–549.
29. Nguyen, K.D., Qiu, Y., Cui, X., Goh, Y.P., Mwangi, J., David, T., Mukundan, L., Brombacher, F., Locksley, R.M., Chawla, A., Alternatively activated macrophages produce catecholamines to sustain adaptive thermogenesis. Nature 480 (2011), 104–108.
30. Nonogaki, K., Hazama, M., Satoh, N., Liraglutide suppresses obesity and hyperglycemia associated with increases in hepatic fibroblast growth factor 21 production in KKAy mice. BioMed Res. Int., 2014, 2014, 751930.
31. O'Shea, D., Gunn, I., Chen, X., Bloom, S., Herbert, J., A role for central glucagon-like peptide-1 in temperature regulation. Neuroreport 7 (1996), 830–832.
32. Qiu, Y., Nguyen, K.D., Odegaard, J.I., Cui, X., Tian, X., Locksley, R.M., Palmiter, R.D., Chawla, A., Eosinophils and type 2 cytokine signaling in macrophages orchestrate development of functional beige fat. Cell 157 (2014), 1292–1308.
33. Samms, R.J., Smith, D.P., Cheng, C.C., Antonellis, P.P., Perfield, J.W. 2nd, Kharitonenkov, A., Gimeno, R.E., Adams, A.C., Discrete aspects of FGF21 in vivo pharmacology do not require UCP1. Cell Rep. 11 (2015), 991–999.
34. Schipper, H.S., Rakhshandehroo, M., van de Graaf, S.F., Venken, K., Koppen, A., Stienstra, R., Prop, S., Meerding, J., Hamers, N., Besra, G., et al. Natural killer T cells in adipose tissue prevent insulin resistance. J. Clin. Invest. 122 (2012), 3343–3354.
35. Turton, M.D., O'Shea, D., Gunn, I., Beak, S.A., Edwards, C.M., Meeran, K., Choi, S.J., Taylor, G.M., Heath, M.M., Lambert, P.D., et al. A role for glucagon-like peptide-1 in the central regulation of feeding. Nature 379 (1996), 69–72.
36. van Can, J., Sloth, B., Jensen, C.B., Flint, A., Blaak, E.E., Saris, W.H., Effects of the once-daily GLP-1 analog liraglutide on gastric emptying, glycemic parameters, appetite and energy metabolism in obese, non-diabetic adults. Int. J. Obes. 38 (2014), 784–793.
37. Wang, Y.C., McPherson, K., Marsh, T., Gortmaker, S.L., Brown, M., Health and economic burden of the projected obesity trends in the USA and the UK. Lancet 378 (2011), 815–825.
38. Yang, M., Zhang, L., Wang, C., Liu, H., Boden, G., Yang, G., Li, L., Liraglutide increases FGF-21 activity and insulin sensitivity in high fat diet and adiponectin knockdown induced insulin resistance. PLoS ONE, 7, 2012, e48392.